Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA
暂无分享,去创建一个
John Kuriyan | Mike O'Donnell | Jerard Hurwitz | J. Gulbis | J. Kuriyan | Z. Kelman | M. O’Donnell | J. Hurwitz | Jacqueline M Gulbis | Zvi Kelman
[1] M. Nakanishi,et al. The C-terminal Region of p21 Is Involved in Proliferating Cell Nuclear Antigen Binding but Does Not Appear to Be Required for Growth Inhibition (*) , 1995, The Journal of Biological Chemistry.
[2] P. O'Connor,et al. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA. , 1995, Oncogene.
[3] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[4] C. Sherr,et al. D-type cyclins. , 1995, Trends in biochemical sciences.
[5] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[6] A. Sancar,et al. Purification of PCNA as a nucleotide excision repair protein. , 1992, Nucleic acids research.
[7] I. Herskowitz,et al. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle , 1994, Cell.
[8] Anindya Dutta,et al. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. , 1996, Nucleic acids research.
[9] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.
[10] S. Elledge,et al. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Bravo,et al. Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[12] Structure determination of plastocyanin from a specimen with a hemihedral twinning fraction of one-half. , 1993, Acta crystallographica. Section D, Biological crystallography.
[13] John Kuriyan,et al. Three-dimensional structure of the β subunit of E. coli DNA polymerase III holoenzyme: A sliding DNA clamp , 1992, Cell.
[14] R. Wood,et al. Proliferating cell nuclear antigen is required for DNA excision repair , 1992, Cell.
[15] J. R. Smith,et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.
[16] James M. Roberts,et al. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.
[17] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[18] A T Brünger,et al. Slow-cooling protocols for crystallographic refinement by simulated annealing. , 1990, Acta crystallographica. Section A, Foundations of crystallography.
[19] G. Hannon,et al. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.
[20] D. Bacon,et al. A fast algorithm for rendering space-filling molecule pictures , 1988 .
[21] Hui Zhang,et al. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA , 1992, Cell.
[22] J. Maller,et al. Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[24] Axel T. Brunger,et al. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .
[25] Philip D. Jeffrey,et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.
[26] U. Hübscher,et al. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. , 1995, Biochemistry.
[27] G. Landberg,et al. Determination of the epitope of an inhibitory antibody to proliferating cell nuclear antigen. , 1996, Experimental cell research.
[28] B. Ducommun,et al. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. , 1995, Oncogene.
[29] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.
[30] R. Laskey,et al. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence , 1991, Cell.
[31] E. Ohtsuka,et al. Structure-Function Relationship of the Eukaryotic DNA Replication Factor, Proliferating Cell Nuclear Antigen (*) , 1995, The Journal of Biological Chemistry.
[32] C. Turck,et al. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.
[33] U. Strausfeld,et al. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repair , 1994, Current Biology.
[34] P. Burgers,et al. Molecular cloning, structure and expression of the yeast proliferating cell nuclear antigen gene. , 1990, Nucleic acids research.
[35] D. Lane,et al. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen , 1995, Current Biology.
[36] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[37] J. Massagué,et al. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.
[38] S. Matsuoka,et al. D-type cyclin-binding regions of proliferating cell nuclear antigen. , 1994, The Journal of biological chemistry.
[39] P. O'Connor,et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.
[40] Z. Kelman,et al. Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps. , 1995, Nucleic acids research.
[41] G. Hannon,et al. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage , 1996, Current Biology.
[42] L. Cox,et al. Characterisation of the interaction between PCNA and Gadd45. , 1995, Oncogene.
[43] John Kuriyan,et al. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA , 1994, Cell.
[44] Bert Vogelstein,et al. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.
[45] M. Kirschner,et al. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.
[46] J. Hurwitz,et al. Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.